| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 1941-1947, Copyright © 1995 by Endocrine Society
ARTICLES |
S Inkster, W Yue and A Brodie
Department of Pharmacology and Experimental Therapeutics, School of Medicine, University of Maryland, Baltimore 21201, USA.
The location of the aromatase enzyme in the testes of human subjects ages 3 months to 72 yr was determined immunocytochemically using a monoclonal antibody specific to human aromatase. In addition, an assay was developed to measure aromatase activity in suspensions of cryosections in order to validate the presence and to quantitate the activity of aromatase in the sections. In mature testes, aromatase immunostain was always associated with Leydig cells and was absent from Sertoli cells. Aromatase activity ranged from 0.014-0.55 pmol estrogen per mg/h and was significantly correlated with the immunostain intensity (P < 0.02). Thus, the aromatase activity provided a semiquantitative estimate of the immunoreaction. Activity and immunostain intensity of aromatase did not correlate with increasing age. Rather, the highest levels were measured in four of six testes of men ages 18-20 yr, three of whom also had the strongest immunostain for aromatase. The Leydig cell clusters of these subjects were larger and more prominent than those in the other specimens. A low level of aromatase activity but no immunostain was detected in prepubertal testes. Aromatase was not detected by either method in normal tissue from the testis of a patient with testicular cancer.
This article has been cited by other articles:
 |
|
 |
|
  R. Sirianni, A. Chimento, R. Malivindi, I. Mazzitelli, S. Ando, and V. Pezzi Insulin-Like Growth Factor-I, Regulating Aromatase Expression through Steroidogenic Factor 1, Supports Estrogen-Dependent Tumor Leydig Cell Proliferation Cancer Res., September 1, 2007; 67(17): 8368 - 8377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C K Hilleson-Gayne and J A Clapper Effects of decreased estradiol-17{beta} on the serum and anterior pituitary IGF-I system in pigs J. Endocrinol., December 1, 2005; 187(3): 369 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Albrecht, R. B. Billiar, G. W. Aberdeen, J. S. Babischkin, and G. J. Pepe Expression of Estrogen Receptors {alpha} and {beta} in the Fetal Baboon Testisand Epididymis Biol Reprod, April 1, 2004; 70(4): 1106 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Lance, A. J. Conley, S. Mapes, C. Steven, and A. R. Place Does Alligator Testis Produce Estradiol? A Comparison of Ovarian and Testicular Aromatase Biol Reprod, October 1, 2003; 69(4): 1201 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aquila, D. Sisci, M. Gentile, A. Carpino, E. Middea, S. Catalano, V. Rago, and S. Ando Towards a physiological role for cytochrome P450 aromatase in ejaculated human sperm Hum. Reprod., August 1, 2003; 18(8): 1650 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lambard, I. Galeraud-Denis, H. Bouraima, S. Bourguiba, A. Chocat, and S. Carreau Expression of aromatase in human ejaculated spermatozoa: a putative marker of motility Mol. Hum. Reprod., March 1, 2003; 9(3): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aquila, D. Sisci, M. Gentile, E. Middea, L. Siciliano, and S. Ando Human Ejaculated Spermatozoa Contain Active P450 Aromatase J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3385 - 3390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Luboshitzky, Z. Shen-Orr, R. Nave, S. Lavi, and P. Lavie Melatonin Administration Alters Semen Quality in Healthy Men J Androl, July 1, 2002; 23(4): 572 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pentikäinen, K. Erkkilä, L. Suomalainen, M. Parvinen, and L. Dunkel Estradiol Acts as a Germ Cell Survival Factor in the Human Testis in Vitro J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2057 - 2067. [Abstract] [Full Text]
|
|
|
|
|
|
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4677 - 4694. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Stratakis, A. Vottero, A. Brodie, L. S. Kirschner, D. DeAtkine, Q. Lu, W. Yue, C. S. Mitsiades, A. W. Flor, and G. P. Chrousos The Aromatase Excess Syndrome Is Associated with Feminization of Both Sexes and Autosomal Dominant Transmission of Aberrant P450 Aromatase Gene Transcription J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1348 - 1357. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Carani, K. Qin, M. Simoni, M. Faustini-Fustini, S. Serpente, J. Boyd, K. S. Korach, and E. R. Simpson Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency N. Engl. J. Med., July 10, 1997; 337(2): 91 - 95. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Furbass, C. Kalbe, and J. Vanselow Tissue-Specific Expression of the Bovine Aromatase-Encoding Gene Uses Multiple Transcriptional Start Sites and Alternative First Exons Endocrinology, July 1, 1997; 138(7): 2813 - 2819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Y. Guo, T. H. Jones, and R. Eastell Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 658 - 665. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
